Doctor profile · Federal record
Dr. Robert Moraru, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1285705061
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 31 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
111 Broadway, Suite 800
New York, NY 100061901
(212) 732-2777
fax (212) 732-4806
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- September 18, 2007
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #204819
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285705061. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,096
Distinct HCPCS
10
Medicare allowed
$130,502
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 898 | 113 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 366 | 202 | $104 | |
17000 |
Destruction of precancer skin growth, 1 growth | 324 | 147 | $73 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 118 | 61 | $147 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 85 | 85 | $132 | |
17110 |
Destruction of skin growth, 1-14 growths | 72 | 33 | $137 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 72 | 60 | $66 | |
11102 |
Biopsy of related skin growth, first growth | 69 | 63 | $118 | |
11900 |
Injection into skin growth, 1-7 growths | 26 | 11 | $46 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | 11 | $1 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$2,121
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 33 | $564.14 | |
| ABBVIE INC. | 19 | $336.96 | |
| UCB, Inc. | 7 | $158.06 | |
| Dermavant Sciences, Inc. | 7 | $156.15 | |
| Regeneron Healthcare Solutions, Inc. | 5 | $152.58 | |
| Verrica Pharmaceuticals Inc. | 4 | $98.75 | |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $94.44 | |
| Lilly USA, LLC | 4 | $84.73 | |
| Amgen Inc. | 4 | $70.03 | |
| GENZYME CORPORATION | 2 | $67.77 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $62.75 | |
| LEO Pharma Inc. | 3 | $57.57 | |
| PFIZER INC. | 3 | $49.19 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.09 | |
| STRATA Skin Sciences, Inc. | 3 | $36.95 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
458
Patients
233
Total drug cost
$16,116
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 73 | 48 | $862 |
| Clobetasol Propionate | Generic | 61 | 39 | $4,100 |
| Ketoconazole | Generic | 50 | 22 | $1,382 |
| Hydrocortisone | Generic | 45 | 34 | $539 |
| Doxycycline Hyclate | Generic | 32 | 17 | $648 |
| Mupirocin | Generic | 30 | 21 | $307 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 30 | 11 | $1,274 |
| Metronidazole | Generic | 29 | 16 | $2,247 |
| Clindamycin Phosphate | Generic | 20 | 12 | $1,980 |
| Econazole Nitrate | Generic | 20 | 13 | $740 |
Frequently asked questions
What is Dr. Robert Moraru's medical specialty?
Dr. Robert Moraru practices Dermatology Physician in New York, NY.
Where does Dr. Robert Moraru practice?
Dr. Robert Moraru practices at 111 Broadway, New York, NY 100061901. Office phone: 2127322777.
What is Dr. Robert Moraru's NPI?
Dr. Robert Moraru's National Provider Identifier (NPI) is 1285705061, issued by NPPES.
Does Dr. Robert Moraru accept Medicare assignment?
Yes. Dr. Robert Moraru accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Moraru commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.